Benefits of Physical Training in Sarcoidosis

Lung

Volumn 193, Issue 5, 2015, Pages 701-708

  Strookappe, Bert ^a,b   Swigris, Jeff ^c   De Vries, Jolanda ^b,d   Elfferich, Marjon ^b   Knevel, Ton ^a   Drent, Marjolein ^b,e,f  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

^b ild care foundation research team   (Netherlands)

^c DEPARTMENT OF MEDICINE   (United States)

^d TILBURG UNIVERSITY   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Exercise limitation; Physical training; Rehabilitation; Sarcoidosis

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; EXERCISE; FATIGUE; FEMALE; FORCED VITAL CAPACITY; FUNCTION TEST; HUMAN; LUNG CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SIX MINUTE WALK DISTANCE; SKELETAL MUSCLE; STEEP RAMP TEST; TRAINING; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAL CAPACITY;

ADULT; EXERCISE TEST; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, HUMAN; RETROSPECTIVE STUDIES; SARCOIDOSIS; VITAL CAPACITY;

EID: 84942552283     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9784-9     Document Type: Article

References (44)

1. (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2):736–755
2. Baughman RP, Culver DA, Judson MA (2011) A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 183(5):573–581
3. Iannuzzi MC, Fontana JR (2011) Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 305(4):391–399
4. Valeyre D, Nunes H, Bernaudin JF (2014) Advanced pulmonary sarcoidosis. Curr Opin Pulm Med 20(5):488–495
5. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J (2014) Sarcoidosis. Lancet 383(9923):1155–1167
6. Drent M, Strookappe B, Hoitsma E, De Vries J (2015) Consequences of sarcoidosis. Clin Chest Med (in press)
7. Marcellis RG, Lenssen AF, Elfferich MD, De Vries J, Kassim S, Foerster K, Drent M (2011) Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J 38(3):628–634
8. Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, Demedts MG, Decramer M (2005) Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 60(1):32–38
9. Marcellis RG, Lenssen AF, de Vries J, Drent M (2013) Reduced muscle strength, exercise intolerance and disabling symptoms in sarcoidosis. Curr Opin Pulm Med 19(5):524–530
10. Marcellis RGJ, Lenssen AF, Kleynen S, De Vries J, Drent M (2013) Exercise capacity, muscle strength and fatigue in sarcoidosis: a follow-up study. Lung 191(3):247–256
11. Drent M, Marcellis R, Lenssen A, De Vries J (2014) Association between physical functions and quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 31(2):117–128
12. Spruit MA, Singh SJ, Garvey C et al (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188(8):e13–e64
13. Marcellis RG, Veeke MAF, Mesters I, Drent M, de Bie RA, de Vries GJ, Lenssen AF (2015) Does physical training reduce fatigue in sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis 32(1):53–62
14. Spruit MA, Wouters EFM, Gosselink R (2005) Rehabilitation programmes in sarcoidosis: a multidisciplinary approach. Eur Respir Mon 32:316–326
15. Braam AW, de Haan SN, Vorselaars AD, Rijkers GT, Grutters JC, van den Elshout FJ, Korenromp IH (2013) Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis. Brain Behav Immun 33:57–64
16. Holland A, Hill C (2008) Physical training for interstitial lung disease. Cochrane Database Syst Rev 4:CD006322
17. Swigris JJ, Brown KK, Make BJ, Wamboldt FS (2008) Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med 102(12):1675–1680
18. Strookappe B, Elfferich MDP, Swigris JJ, Verschoof AC, Verschakelen JA, Knevel T, Drent M (2015) Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study. Sarcoidosis Vasc Diffuse Lung Dis 32(1):43–52
19. Cremers JP, Drent M, Elfferich MD, Nelemans PJ, Wijnen PA, Witteman BJ, Schols AM (2013) Body composition profiling in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 30(4):289–299
20. Werle S, Goldhahn J, Drerup S, Simmen BR, Sprott H, Herren DB (2009) Age- and gender-specific normative data of grip and pinch strength in a healthy adult Swiss population. J Hand Surg Eur 34(1):76–84
21. Mathiowetz V, Wiemer DM, Federman SM (1986) Grip and pinch strength: norms for 6- to 19-year-olds. Am J Occup Ther 40(10):705–711
22. Bohannon RW (1988) Make tests and break tests of elbow flexor muscle strength. Phys Ther 68(2):193–194
23. Meyer K, Samek L, Schwaibold M, Westbrook S, Hajric R, Lehmann M, Essfeld D, Roskamm H (1996) Physical responses to different modes of interval exercise in patients with chronic heart failure-application to exercise training. Eur Heart J 17(7):1040–1047
24. De Backer IC, Schep G, Hoogeveen A, Vreugdenhil G, Kester AD, van Breda E (2007) Exercise testing and training in a cancer rehabilitation program: the advantage of the steep ramp test. Arch Phys Med Rehabil 88(5):610–616
25. McArdle WD, Katch FI, Katch VL (2007) Exercise physiology: energy, nutrition, & human performance, 7th edn. Lippincott Williams and Wilkins, Baltimore
26. ATS Commitee (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117
27. Gibbons WJ, Fruchter N, Sloan S, Levy RD (2001) Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 21(2):87–93
28. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J (2006) Fatigue is associated with quality of life in sarcoidosis patients. Chest 130(4):989–994
29. De Kleijn WP, De Vries J, Wijnen PA, Drent M (2011) Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respir Med 105(9):1388–1395
30. Skevington SM, Pilaar M, Routh D, MaCleod RD (1997) On the language of breathlessness. Psychol Health 12:677–689
31. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381
32. Marcellis RG, Lenssen AF, Kleynen S, De Vries J, Drent M (2013) Exercise capacity, muscle strength, and fatigue in sarcoidosis: a follow-up study. Lung 191(3):247–256
33. Marcellis RG, Lenssen AF, de Vries GJ, Baughman RP, van der Grinten CP, Verschakelen JA, De Vries J, Drent M (2013) Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients? Lung 191(1):43–52
34. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF (2008) Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 63(6):549–554
35. Huppmann P, Sczepanski B, Boensch M, Winterkamp S, Schonheit-Kenn U, Neurohr C, Behr J, Kenn K (2013) Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 42(2):444–453
36. Ries AL (2008) Pulmonary rehabilitation: summary of an evidence-based guideline. Respir Care 53(9):1203–1207
37. Ryerson CJ, Garvey C, Collard HR (2010) Pulmonary rehabilitation for interstitial lung disease. Chest 138(1):240–241 author reply 241–242
38. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, Polkey MI, Moxham J (2003) Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168(5):562–567
39. Baughman RP, Lower EE, Gibson K (2012) Pulmonary manifestations of sarcoidosis. Presse Med 41(6 Pt 2):e289–e302
40. Drent M, Lower EE, De Vries J (2012) Sarcoidosis-associated fatigue. Eur Respir J 40(1):255–263
41. De Vries J, Drent M (2008) Quality of life and health status in sarcoidosis: a review of the literature. Clin Chest Med 29(3):525–532
42. Hinz A, Brähler E, Möde R, Wirtz H, Bosse-Henck A (2012) Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea. Sarcoidosis Vasc Diffuse Lung Dis 29:139–146
43. Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M (2010) Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80(3):212–219
44. Judson MA (2011) Small fiber neuropathy in sarcoidosis: something beneath the surface. Respir Med 105(1):1–2